Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]

Maria C. Sorbo; Valeria Cento; Velia C. Di Maio; Anita Y.M. Howe; Federico Garcia; Carlo F. Perno; Francesca Ceccherini-Silberstein

首页> 外文期刊>Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy >Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]

【24h】

Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]

机译：“丙型肝炎病毒耐药相关取代的勘探及其临床相关性：更新2018”[毒品抗蚀剂。更新37（3月）（2018）17-39]

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy》 |2018年第2018期|共2页
作者
Maria C. Sorbo; Valeria Cento; Velia C. Di Maio; Anita Y.M. Howe; Federico Garcia; Carlo F. Perno; Francesca Ceccherini-Silberstein;
展开▼
作者单位

Department of Experimental Medicine and Surgery University of Rome Tor Vergata;

Residency Program in Microbiology and Virology Università degli Studi di Milano;

Department of Experimental Medicine and Surgery University of Rome Tor Vergata;

Centre for Excellence in HIV/AIDS St Paul’s Hospital;

Clinical Microbiology Service Hospital Universitario San Cecilio;

Department of Oncology and Oncohematology Università degli Studi di Milano;

Department of Experimental Medicine and Surgery University of Rome Tor Vergata;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39] [J] . Maria C. Sorbo, Valeria Cento, Velia C. Di Maio, Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy . 2018,第期

机译：“丙型肝炎病毒耐药相关取代的勘探及其临床相关性：更新2018”[毒品抗蚀剂。更新37（3月）（2018）17-39]
2. Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities’ [Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222] [J] . Kathrin K. Geyer, Sabrina E. Munshi, Martin Vickers, International Journal for Parasitology: Drugs and Drug Resistance . 2018,第3期

机译：“ 5-氮杂胞苷（5-AzaC）对曼氏血吸虫的抗生殖力作用的勘误与转录，翻译和干细胞活性的失调有关”。 J．药物和抗药性。 8（2018）213–222]
3. Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections Boston, Massachusetts, USA - March 4-7, 2018 [J] . Rizza S. A., Bhatia R., Temesgen Z. Drugs of the Future . 2018,第4期

机译：新型艾滋病毒药物和药物交付策略。 2018年逆转录病毒会议和机会性感染波士顿，马萨诸塞州，美国的报告 - 2018年3月4日至7日
4. MALDI-TOF MS for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy [C] . Magda Rybicka, Piotr Stalke, Tomasz Smiatacz, International Mass Spectrometry Conference . 2014

机译：MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
5. Drug resistance mechanisms and drug design strategies for human immunodeficiency virus and hepatitis C virus proteases [D] . Wang, Yong 2012

机译：人类免疫缺陷病毒和丙型肝炎病毒蛋白酶的耐药机制和药物设计策略
6. Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription translation and stem cell activities’ Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222 [O] . Kathrin K. Geyer, Sabrina E. Munshi, Martin Vickers, 2018

机译：5-氮杂胞苷（5-AzaC）对曼氏血吸虫的抗生殖力作用的勘误与转录翻译和干细胞活性失调有关。 J．药物和抗药性。 8（2018）213–222
7. Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities’ Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222 [O] . Kathrin K. Geyer, Sabrina E. Munshi, Martin Vickers, 2018

机译：“5-氮杂胞苷（5-AZAC）对血吸虫麦森的抗繁殖作用的勘测与分类的转录，翻译和干细胞活性相关联。 J.Agaritol。药物和药物抗蚀剂。 8（2018）213-222

Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]

著录项

相似文献

相关主题

期刊订阅